Obstetrics/Gynecology Market Research Reports & Industry Analysis
Obstetrics/Gynecology Industry Research & Market Reports
-
Intrauterine Devices (IUD) Market Report by Product (Hormonal Intrauterine Device, Copper Intrauterine Device), End-Use (Hospitals, Gynaecology Clinics, Community Healthcare, and Others), and Region 2025-2033
... The market is propelled by the rising awareness about long-acting reversible contraception (LARC), significant technological advancements in IUD design and insertion techniques, favorable government initiatives promoting family planning and contraception access. Intrauterine Devices (IUDs) are ... Read More
-
Contraceptive Drugs And Devices Market Size, Share & Trends Analysis Report By Product (Contraceptive Drugs (Pills, Patch, Injectable), Contraceptive Devices), By Region, And Segment Forecasts, 2025 - 2030
... factors are contributing to the growth of the contraceptive market. Increasing awareness and education about reproductive health, a rising demand for family planning methods, improved healthcare infrastructure and access, and a shift in consumer preferences ... Read More
-
Cervical Cancer Endoscopic Devices
... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Optical Colposcopes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$668.1 Million by the ... Read More
-
Women's Health Rehabilitation Products Market Analysis and Forecast to 2033: Type: (Physical Therapy, Occupational Therapy, Speech Therapy, Aquatic Therapy), Product: (Pelvic Floor Exercisers, Posture Correctors, Therapeutic Ultrasound Devices, Electrical Stimulation Devices, Compression Garments, Support Braces, Heat Therapy Products, Cold Therapy Products), Services: (Consultation Services, Rehabilitation Programs, Tele-rehabilitation, Home Care Services, In-patient Services, Out-patient Services, Customized Therapy Plans), Technology: (Wearable Technology, Mobile Health Apps, Virtual Reality, Artificial Intelligence, 3D Printing, Robotics), Component: (Hardware, Software, Services), Application: (Chronic Pain Management, Post-surgical Recovery, Pregnancy and Postpartum Care, Menopause Management, Injury Rehabilitation), Device: (Handheld Devices, Portable Devices, Stationary Devices), End User: (Hospitals, Clinics, Homecare Settings, Rehabilitation Centers), Functionality: (Monitori
... devices and solutions designed to aid recovery and improve quality of life for women experiencing health challenges. This market includes pelvic floor exercisers, maternity care products, and post-operative rehabilitation aids, addressing conditions such as postpartum ... Read More
-
Vaginitis Therapeutics
... CAGR of 7.6% over the analysis period 2024-2030. Anti-Bacterial Product, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Intravaginal Insemination
... CAGR of 7.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$130.1 Million While China is Forecast to Grow at 10.8% CAGR The Intravaginal Insemination market in the U.S. is estimated at ... Read More
-
Microwave Ablation
... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the ... Read More
-
Intrauterine Insemination
... CAGR of 8.1% over the analysis period 2024-2030. The U.S. Market is Estimated at US$464.8 Million While China is Forecast to Grow at 11.7% CAGR The Intrauterine Insemination market in the U.S. is estimated at ... Read More
-
Energy-based Therapeutics
... CAGR of 3.6% over the analysis period 2024-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Amniocentesis Needles
... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end ... Read More
-
Endometrial Cancer Treatment
... at a CAGR of 5.0% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$31.3 Billion by the end of the ... Read More
-
Gynecological Cancer Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.1 Billion by the end of ... Read More
-
Endometriosis Drugs
... CAGR of 3.0% over the analysis period 2024-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Hormone Replacement Therapy (HRT)
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$24.2 Billion ... Read More
-
Prenatal Diagnostics
... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis ... Read More
-
Cervical Cancer Treatment
... at a CAGR of 6.0% over the analysis period 2024-2030. Squamous Cell Carcinoma (SCC) Treatment, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$9.1 Billion by ... Read More
-
Polycystic Ovary Syndrome (PCOS) Treatment
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Insulin-Sensitizing Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.3 Billion ... Read More
-
Human Reproductive Technologies
... at a CAGR of 2.2% over the analysis period 2024-2030. Contraceptive Drugs & Devices Technology, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$22.0 Billion by ... Read More
-
Uterine Cancer Therapeutics and Diagnostics
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Endometrial Carcinomas Therapeutics & Diagnostics, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and ... Read More
-
Global Ovarian Cancer Drugs Market - 2024-2032
... during the forecast period 2024-2031. Ovarian cancer is the growth of abnormal cancerous cells in the ovaries, fallopian tube, or peritoneum- the major parts of the woman’s reproductive system. Ovaries are made up of different ... Read More
-
Global Hormone Replacement Therapy Market - 2024 - 2032
... of 6.1% during the forecast period 2024-2032. Hormone Replacement Therapy (HRT) is a treatment that involves the use of hormones to address symptoms linked to hormonal imbalances, particularly during menopause, as well as in conditions ... Read More
-
High Intensity Focused Ultrasound Market Size, Share & Trends Analysis Report By Application (Dermatology, Uterine Fibroids, Prostate Cancer, Essential Tremor), By End-use (Hospitals, Imaging Centers), By Region, And Segment Forecasts, 2025 - 2030
... to a new report by Grand View Research, Inc. The increasing prevalence of cancer and other chronic diseases, coupled with the growing demand for non-invasive treatment options, is expected to drive market growth. In addition, ... Read More
-
Assisted Reproductive Technology Global Market Report 2025
... End-User: Hospitals; Fertility ClinicsCovering: Cooper Surgical Inc.; Ferring Pharmaceuticals Ltd.; Hamilton Thorne Ltd.; Merck KGaA; Genea Limited Assisted Reproductive Technology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033
... Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2025-2033 The global biosimilar market size reached USD 26.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 185.1 Billion by 2033, exhibiting ... Read More
-
2025 Global: Estrogen Replacement Therapy Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
Research Assistance
